Recommended Syrup Medications for Cough
For adults and children over 12 years with non-specific cough, dextromethorphan syrup at 30-60 mg is the preferred first-line pharmacological option due to its superior safety profile compared to codeine-based alternatives, though simple honey and lemon mixtures should be tried first. 1, 2
Age-Specific Dosing for Dextromethorphan Syrup
- Adults and children ≥12 years: 10 mL (30 mg) every 12 hours, maximum 20 mL (60 mg) in 24 hours 3
- Children 6 to <12 years: 5 mL (15 mg) every 12 hours, maximum 10 mL (30 mg) in 24 hours 3
- Children 4 to <6 years: 2.5 mL (7.5 mg) every 12 hours, maximum 5 mL (15 mg) in 24 hours 3
- Children <4 years: Do not use 3
Treatment Algorithm by Patient Population
For Adults with Acute Viral Cough
Step 1: Non-pharmacological approach
- Start with honey and lemon mixture, which is as effective as many pharmacological treatments and has no side effects 1, 2, 4
- Encourage voluntary cough suppression through central modulation 2
Step 2: Pharmacological treatment if needed
- Dextromethorphan syrup 30-60 mg provides optimal cough suppression with a clear dose-response relationship 1, 2
- Standard over-the-counter doses (15-30 mg) are often subtherapeutic; maximum suppression occurs at 60 mg 2, 4
- Critical pitfall: Many OTC preparations contain subtherapeutic doses—prescribe adequate amounts 2
Step 3: For nocturnal cough disrupting sleep
- First-generation sedating antihistamines (e.g., diphenhydramine) are particularly useful due to their sedative properties 1, 2, 4
For Children with Non-Specific Cough
OTC cough medications have minimal benefit and significant risks in children 5
- The American Academy of Pediatrics advises against codeine and dextromethorphan for any type of cough in children 5
- OTC cough remedies are associated with significant morbidity and mortality in children, particularly those <5 years 5
- For children, honey (age >1 year) is safer and equally effective as pharmacological options 1, 2
For Patients with Chronic Bronchitis
- Peripheral cough suppressants (levodropropizine, moguisteine) are recommended for short-term symptomatic relief 5
- Central suppressants (codeine, dextromethorphan) are also effective but should be used short-term only 5
- Ipratropium bromide inhaled is the only anticholinergic recommended for cough suppression 5, 1
For Patients with Lung Cancer
- Start with glycerol-based cough syrups or butamirate citrate syrup (Sinecod), which showed benefit in this population 5
- If ineffective, escalate to opioid derivatives: pholcodine, hydrocodone, dihydrocodeine, or morphine (codeine is less preferred due to greater side effects) 5
- Dextromethorphan 10-15 mg three to four times daily, maximum 120 mg/day 4
What NOT to Prescribe
Codeine-containing syrups should be avoided 1, 2, 4
- Codeine has no greater efficacy than dextromethorphan but significantly more adverse effects (drowsiness, nausea, constipation, physical dependence) 1, 2
- The British Thoracic Society specifically recommends against codeine due to its poor benefit-to-risk ratio 1, 2
Avoid in specific situations:
- Central cough suppressants have limited efficacy for upper respiratory infection cough and are not recommended 5, 1
- Do not suppress productive cough where secretion clearance is beneficial 4
- Albuterol is not recommended for cough not due to asthma 5
Critical Safety Considerations
Check combination products carefully 4
- Many dextromethorphan syrups contain acetaminophen or other ingredients 1, 2
- Higher doses (60 mg) may lead to excessive amounts of combination ingredients 4
Red flags requiring immediate medical evaluation (not just cough syrup):
- Hemoptysis, breathlessness, or tachypnea 2
- Fever with purulent sputum suggesting serious lung infection 2
- Cough persisting >3 weeks requires full diagnostic workup, not continued antitussive therapy 4
Special Populations
Chronic kidney disease patients:
- No dose adjustment needed for dextromethorphan as it is hepatically metabolized, not renally excreted 4
Postinfectious cough (persisting after URI but <8 weeks):